Company Press Releases

Ascendant Resources Announces August 2017 Operational Results

2017-09-20 / @nasdaq

Second consecutive month of positive adjusted EBITDATonnes milled increased to 1,903 tpd, up 9.8% from Q2 average and 53% from January 2017Fleet renewal in-process with new equipment orderedTORONTO, Sept.20, 2017(GLOBE NEWSWIRE) -- Ascendant Resources Inc. (TSX:ASND) (OTCQX:ASDRF) (FRA:2D9) ("As...Read More

Ascendant Resources Launches Virtual Tour of the El Mochito Mine

2017-09-13 / @nasdaq

TORONTO, Sept.13, 2017(GLOBE NEWSWIRE) -- Ascendant Resources Inc. (TSX:ASND) (OTCQX:ASDRF) (FRA:2D9) ("Ascendant" or the "Company") is pleased to announce the launch of its 360 ? virtual tour of the El Mochito Mine located in Honduras. The El Mochito Mine's virtual tour provides an in-depth view...Read More

OTC Markets Group Welcomes Ascendant Resources to OTCQX

2017-09-05 / @newswire

NEW YORK, Sept. 5, 2017 /PRNewswire/ -- OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for 10,000 U.S. and global securities, today announced Ascendant Resources Inc. (TSX: ASND; OTCQX: ASDRF), a mining company focused on operations in Honduras, has qualified to trade on the...Read More

Ascendant Resources Begins Trading on the OTCQX

2017-09-05 / @nasdaq

TORONTO, Sept.05, 2017(GLOBE NEWSWIRE) -- Ascendant Resources Inc. (TSX:ASND) (OTCQX:ASDRF) (FRA:2D9) ("Ascendant" or the "Company") announces that effective immediately its common shares have commenced trading in the United States under the symbol "ASDRF" on the OTCQX (R) Best Market ("OTCQX")....Read More

Ascendis Pharma A/S Announces Presentations on Rare Disease Endocrinology Pipeline at Upcoming Medical Conferences

2017-09-05 / @nasdaq

COPENHAGEN, Denmark, Sept.05, 2017(GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq:ASND), a biopharmaceutical company that utilizes its innovative TransCon technology to address significant unmet medical needs in rare diseases, today announced upcoming posters and presentations related to its rar...Read More

Ascendis Pharma A/S Reports Second Quarter 2017 Financial Results

2017-08-18 / @nasdaq

- Clinical Pipeline Expands to Include TransCon PTH while Phase 3 Program for TransCon Growth Hormone Advances - - Conference Call Today at 8:00 a.m. Eastern Time - COPENHAGEN, Denmark, Aug.18, 2017(GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq:ASND), a biopharmaceutical company that utilizes i...Read More

Ascendant Resources Announces First Month of Positive Adjusted EBITDA Since Acquiring the El Mochito Mine and Reports Second Quarter Financial Results

2017-08-14 / @nasdaq

Adjusted EBITDA1 of $0.7 million for month of July1,853 tonnes milled per day and 57,458 total tonnes milled during the month of July, an increase of 7% compared to Q2/17; August reporting continue improvementAdoption of advance notice by-lawTORONTO, Aug.14, 2017(GLOBE NEWSWIRE) -- Ascendant Res...Read More

Ascendis Pharma A/S Announces Upcoming Investor Presentations

2017-08-08 / @nasdaq

COPENHAGEN, Denmark, Aug.08, 2017(GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq:ASND), a biopharmaceutical company that utilizes its innovative TransCon technology to address significant unmet medical needs in rare diseases, today announced that the company will participate in three upcoming in...Read More

Ascendis Pharma A/S Announces Second Quarter 2017 Financial Results Conference Call on August 18

2017-08-03 / @nasdaq

COPENHAGEN, Denmark, Aug.03, 2017(GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq:ASND), a biopharmaceutical company that utilizes its innovative TransCon technology to address significant unmet medical needs in rare diseases, today announced that the company will hold a conference call and live...Read More

Ascendant Resources Receives Final Approval for Listing on the TSX

2017-07-18 / @nasdaq

TORONTO, July18, 2017(GLOBE NEWSWIRE) -- Ascendant Resources Inc. (TSX-V:ASND) (FRA:2D9) ("Ascendant" or the "Company") is pleased to announce that, further to a June 28, 2017 press release, it has received final approval from the Toronto Stock Exchange ("TSX") to graduate from the TSX Venture E...Read More

Ascendant Resources Provides June and Second Quarter Production Update

2017-07-17 / @nasdaq

Milled production rises 15% against the first quarter 2017Second quarter performance 4% ahead of guidance on equivalent metal production basisTORONTO, July17, 2017(GLOBE NEWSWIRE) -- Ascendant Resources Inc. (TSX-V:ASND) (FRA:2D9) ("Ascendant" or the "Company") announces zinc equivalent metal...Read More

Ascendant Resources Receives Conditional Approval for Listing on the TSX

2017-06-29 / @marketwired

TORONTO, ONTARIO--(Marketwired - June 29, 2017) - Ascendant Resources Inc. (TSX VENTURE:ASND)(FRANKFURT:2D9) ("Ascendant" or the "Company") is pleased to announce that it has received conditional approval from the Toronto Stock Exchange (the "TSX") to graduate from the TSX Ventur...Read More

Ascendant Intersects Significant High-Grade Mineralized Intercepts at Its El Mochito Mine

2017-06-26 / @marketwired

TORONTO, ONTARIO--(Marketwired - June 26, 2017) - Ascendant Resources Inc. (TSX VENTURE:ASND)(FRANKFURT:2D9) ("Ascendant" or the "Company") is pleased to announce results of 29 diamond drill holes (7,447m) as part of its ongoing underground exploration and definition drilling pro...Read More

Ascendant Welcomes Mr. Renaud Adams and Mr. Guillemo Kaelin to Its Board of Directors

2017-06-23 / @marketwired

TORONTO, ONTARIO--(Marketwired - June 23, 2017) - Ascendant Resources Inc. (TSX VENTURE:ASND)(FRANKFURT:2D9) ("Ascendant" or the "Company") is pleased to announce voting results at its Annual and Special Meeting of shareholders on June 21, 2017. All measures put forth in the man...Read More

Ascendant Resources Announces Nomination of Mr. Renaud Adams to its Board of Directors

2017-05-10 / @marketwired

TORONTO, ONTARIO--(Marketwired - May 10, 2017) - Ascendant Resources Inc. (TSX VENTURE:ASND) ("Ascendant" or the "Company") is very pleased to announce that Mr. Renaud Adams, P. Eng will stand for election to the Company's Board of Directors at the upcoming Annual and Specia...Read More

Ascendis Pharma A/S Announces First Quarter 2017 Financial Results Conference Call on May 23

2017-05-11 / @newswire

COPENHAGEN, Denmark, May 11, 2017 /PRNewswire/ -- Ascendis Pharma A/S (Nasdaq: ASND), a biopharmaceutical company that utilizes its innovative TransCon technology to address significant unmet medical needs in rare diseases, today announced that the company will hold a conference call and live web...Read More

Ascendant Announces Nomination of Guillermo Kaelin to Stand for Election to its Board of Directors

2017-05-16 / @marketwired

TORONTO, ONTARIO--(Marketwired - May 16, 2017) - Ascendant Resources Inc. (TSX VENTURE:ASND) ("Ascendant" or the "Company") is very pleased to announce that Mr. Guillermo Kaelin will stand for election to the Company's Board of Directors at the upcoming Annual and Special Me...Read More

Ascendis Pharma A/S Reports First Quarter 2017 Financial Results

2017-05-23 / @newswire

COPENHAGEN, Denmark, May 23, 2017 /PRNewswire/ -- Ascendis Pharma A/S (Nasdaq: ASND), a biopharmaceutical company that utilizes its innovative TransCon technology to address significant unmet medical needs in rare diseases, today announced financial results for the quarter ended March 31, 2017....Read More

Ascendant Resources Provides May Production & Exploration Update

2017-06-12 / @marketwired

EL MOCHITO, HONDURAS--(Marketwired - June 12, 2017) - Low availability and utilization rates for aging mobile equipment impacted production; new equipment arrivals currently underway Ascendant Resources Inc. (TSX VENTURE:ASND) ("Ascendant" or the "Company") announces...Read More

Share to Youtube Share to Facebook Facebook Share to Linkedin Share to Twitter Twitter Share to Tiktok